All updated as on -
Having been valued at USD 4.8 Billion in 2022, the Insulin Pumps Market Size is expected to increase from USD 4.78 Billion in 2023 to USD 14.99 Billion by 2030, expanding at a CAGR (compound annual growth rate) of 16.50% between 2023 and 2030. Market expansion is being fueled by factors such as the increasing prevalence of diabetes and consumer focus on health. Market growth has also been fueled by factors such as rising per capita healthcare spending and improved insulin pump performance research and development.
Insulin pumps are portable, battery-operated computers that are configured to administer insulin to a diabetic at regular intervals. To meet the needs of the growing diabetic population, the market for these pumps has expanded in recent years. The rising incidence of diabetes, especially type 1 diabetes, is one of the main drivers of the market. Leading medical device companies' development of high-tech pumps run on cutting-edge technologies like AI and ML has also emerged as an important growth element for the industry.
Market expansion is being driven by reasons such as technological progress and the increasing preference for insulin pumps over older techniques. Those who need many daily injections of insulin can benefit greatly from using an insulin pump. Since these tools are less invasive, they have found widespread use among patients. The rising prevalence of diabetes and obesity, as well as the ageing population, are driving factors in the expansion of the market. New insulin pumps are being developed with cutting-edge technology to improve compliance and integration with IT devices, both of which are fueling the industry's expansion. Artificial pancreas and home infusion therapy are two examples of emerging technologies that are expected to open up expansive new markets in the not-too-distant future. The market for insulin pumps has expanded in both developed and developing nations as a result of rising public knowledge of the devices.
The insulin pump is a small, electronic medical device that can be worn on a belt or hidden in a pocket. The insulin pump administers insulin at set intervals based on the user's basal and bolus rates, mitigating the risk of a rapid increase in blood sugar. Key growth reasons include the increasing prevalence of diabetes and consumer awareness of the importance of maintaining a healthy lifestyle. Many lifestyle-related diseases, including diabetes, have seen substantial increases as a result of economic modernization. Preference shifts and increased consumption of ready-to-eat commercial foods, many of which contain artificial additives and preservatives, also contribute positively. Because diabetes is associated with a higher risk of other chronic conditions like kidney failure, stroke, paralysis, and blindness, manufacturers are putting more effort into creating low-cost, flexible equipment. The need for an efficient Insulin Pump has grown alongside the availability of high-precision glucose sensors and blood monitoring equipment. Market growth has also been aided by rising healthcare spending per capita and increased research aimed at enhancing the performance of Insulin Pumps. In contrast, rising insulin costs and unfavourable insurance policies are predicted to slow the insulin pump market over the forecast period. Limiting the growth of the industry is the tight enforcement of rules and regulations for product approval.
Insulin pumps are small, computerised devices that inject the correct amount of insulin into a diabetic patient at regular intervals. Insulin pumps have gained widespread popularity due to its effectiveness in helping people with diabetes manage and control their condition on a daily basis by ensuring that their insulin dosages are always delivered on time. The rising incidence of diabetes is a major factor driving the demand for insulin pumps. The International Diabetes Federation has released estimates that by 2030, over 552 million individuals around the world would have diabetes. The World Health Organisation cites diabetes as a major contributor to visual impairment, cardiovascular disease, and renal failure. An increasing number of individuals around the world are developing diabetes due to changes in consumer lifestyle, consumption patterns, and people's bad eating habits.
The global insulin pump market is expanding as a result of a number of causes, the most prominent ones being the increasing demand for insulin pumps and the widespread availability of insulin pumps. Growth in the market is being fueled by increased investments in drug delivery device research and development, namely in insulin pumps designed with patient convenience in mind. Patients' increased interest in automated insulin pumps can also be attributed to the increasing prevalence of smart technologies like artificial intelligence in healthcare. The global insulin pump market is expanding thanks to factors such as the increasing product approvals and the market participants' use of different types of development strategies, such as partnerships, distribution agreements, and collaborations.
Report Coverage
Global Insulin Pump research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Insulin Pump report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Insulin Pump competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Insulin Pump market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Insulin Pump market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Insulin Pump market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Abbott Laboratories, Braun Melsungen AG, Dickinson and Company, Hoffmann-La Roche AG, and Insulet Corporation.
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Insulin Pump market based on the below-mentioned segments:
Global Insulin Pump Market, By Type
Smart Insulin Pumps
Traditional Insulin Pumps
Disposable Insulin Pumps
Global Insulin Pump market, By Accessories
Insulin Reservoirs
Infusion Sets
Infusion Set Insertion Devices
Global Insulin Pump Market, By End User
Hospitals and Clinics
Home Care
Laboratories
Global Insulin Pump market, Regional Analysis
Insulin pumps are portable, battery-operated computers that are configured to administer insulin to a diabetic at regular intervals. To meet the needs of the growing diabetic population, the market for these pumps has expanded in recent years. The rising incidence of diabetes, especially type 1 diabetes, is one of the main drivers of the market. Leading medical device companies' development of high-tech pumps run on cutting-edge technologies like AI and ML has also emerged as an important growth element for the industry.
Market expansion is being driven by reasons such as technological progress and the increasing preference for insulin pumps over older techniques. Those who need many daily injections of insulin can benefit greatly from using an insulin pump. Since these tools are less invasive, they have found widespread use among patients. The rising prevalence of diabetes and obesity, as well as the ageing population, are driving factors in the expansion of the market. New insulin pumps are being developed with cutting-edge technology to improve compliance and integration with IT devices, both of which are fueling the industry's expansion. Artificial pancreas and home infusion therapy are two examples of emerging technologies that are expected to open up expansive new markets in the not-too-distant future. The market for insulin pumps has expanded in both developed and developing nations as a result of rising public knowledge of the devices.
The insulin pump is a small, electronic medical device that can be worn on a belt or hidden in a pocket. The insulin pump administers insulin at set intervals based on the user's basal and bolus rates, mitigating the risk of a rapid increase in blood sugar. Key growth reasons include the increasing prevalence of diabetes and consumer awareness of the importance of maintaining a healthy lifestyle. Many lifestyle-related diseases, including diabetes, have seen substantial increases as a result of economic modernization. Preference shifts and increased consumption of ready-to-eat commercial foods, many of which contain artificial additives and preservatives, also contribute positively. Because diabetes is associated with a higher risk of other chronic conditions like kidney failure, stroke, paralysis, and blindness, manufacturers are putting more effort into creating low-cost, flexible equipment. The need for an efficient Insulin Pump has grown alongside the availability of high-precision glucose sensors and blood monitoring equipment. Market growth has also been aided by rising healthcare spending per capita and increased research aimed at enhancing the performance of Insulin Pumps. In contrast, rising insulin costs and unfavourable insurance policies are predicted to slow the insulin pump market over the forecast period. Limiting the growth of the industry is the tight enforcement of rules and regulations for product approval.
Insulin pumps are small, computerised devices that inject the correct amount of insulin into a diabetic patient at regular intervals. Insulin pumps have gained widespread popularity due to its effectiveness in helping people with diabetes manage and control their condition on a daily basis by ensuring that their insulin dosages are always delivered on time. The rising incidence of diabetes is a major factor driving the demand for insulin pumps. The International Diabetes Federation has released estimates that by 2030, over 552 million individuals around the world would have diabetes. The World Health Organisation cites diabetes as a major contributor to visual impairment, cardiovascular disease, and renal failure. An increasing number of individuals around the world are developing diabetes due to changes in consumer lifestyle, consumption patterns, and people's bad eating habits.
The global insulin pump market is expanding as a result of a number of causes, the most prominent ones being the increasing demand for insulin pumps and the widespread availability of insulin pumps. Growth in the market is being fueled by increased investments in drug delivery device research and development, namely in insulin pumps designed with patient convenience in mind. Patients' increased interest in automated insulin pumps can also be attributed to the increasing prevalence of smart technologies like artificial intelligence in healthcare. The global insulin pump market is expanding thanks to factors such as the increasing product approvals and the market participants' use of different types of development strategies, such as partnerships, distribution agreements, and collaborations.
Report Coverage
Global Insulin Pump research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Insulin Pump report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Insulin Pump competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Insulin Pump market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2030 |
| Base Year | 2022 |
| Forecast Period | 2022-2030 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Abbott Laboratories, Braun Melsungen AG, Dickinson and Company, Hoffmann-La Roche AG, and Insulet Corporation. |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Insulin Pump Market from 2021 to 2030.
- Market Forecast for Insulin Pump Market from 2021 to 2030.
- Regional Market Share and Revenue from 2021 to 2030.
- Country Market share within region from 2021 to 2030.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Insulin Pump competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Insulin Pump
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Insulin Pump market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Insulin Pump market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Abbott Laboratories, Braun Melsungen AG, Dickinson and Company, Hoffmann-La Roche AG, and Insulet Corporation.
Primary Target Market
- Market Players of Insulin Pump
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Insulin Pump market based on the below-mentioned segments:
Global Insulin Pump Market, By Type
Smart Insulin Pumps
Traditional Insulin Pumps
Disposable Insulin Pumps
Global Insulin Pump market, By Accessories
Insulin Reservoirs
Infusion Sets
Infusion Set Insertion Devices
Global Insulin Pump Market, By End User
Hospitals and Clinics
Home Care
Laboratories
Global Insulin Pump market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive insulin pump market market research and competitor analysis for your business to help you develop more profound insights into the insulin pump market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the insulin pump market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.